257 related articles for article (PubMed ID: 37414222)
1. Emerging nanotechnology for Alzheimer's disease: From detection to treatment.
Song N; Sun S; Chen K; Wang Y; Wang H; Meng J; Guo M; Zhang XD; Zhang R
J Control Release; 2023 Aug; 360():392-417. PubMed ID: 37414222
[TBL] [Abstract][Full Text] [Related]
2. Fluorinated Molecules and Nanotechnology: Future 'Avengers' against the Alzheimer's Disease?
Dabur M; Loureiro JA; Pereira MC
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340267
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in Nanotechnology: A Novel Therapeutic System for the Treatment of Alzheimer's Disease.
Chauhan PS; Yadav D; Koul B; Mohanta YK; Jin JO
Curr Drug Metab; 2020; 21(14):1144-1151. PubMed ID: 33234100
[TBL] [Abstract][Full Text] [Related]
4. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
Viola KL; Klein WL
Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues.
Brambilla D; Le Droumaguet B; Nicolas J; Hashemi SH; Wu LP; Moghimi SM; Couvreur P; Andrieux K
Nanomedicine; 2011 Oct; 7(5):521-40. PubMed ID: 21477665
[TBL] [Abstract][Full Text] [Related]
6. The Potential Benefits of Nanotechnology in Treating Alzheimer's Disease.
Ling TS; Chandrasegaran S; Xuan LZ; Suan TL; Elaine E; Nathan DV; Chai YH; Gunasekaran B; Salvamani S
Biomed Res Int; 2021; 2021():5550938. PubMed ID: 34285915
[TBL] [Abstract][Full Text] [Related]
7. Nanomaterial-based Optical and Electrochemical Biosensors for Amyloid beta and Tau: Potential for early diagnosis of Alzheimer's Disease.
Phan LMT; Hoang TX; Vo TAT; Pham HL; Le HTN; Chinnadayyala SR; Kim JY; Lee SM; Cho WW; Kim YH; Choi SH; Cho S
Expert Rev Mol Diagn; 2021 Feb; 21(2):175-193. PubMed ID: 33560154
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease: review of current nanotechnological therapeutic strategies.
Baranowska-Wójcik E; Szwajgier D
Expert Rev Neurother; 2020 Mar; 20(3):271-279. PubMed ID: 31957510
[No Abstract] [Full Text] [Related]
9. Design principles and fundamental understanding of biosensors for amyloid-β detection.
Zhang Y; Ren B; Zhang D; Liu Y; Zhang M; Zhao C; Zheng J
J Mater Chem B; 2020 Jul; 8(29):6179-6196. PubMed ID: 32355946
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease and its treatment by different approaches: A review.
Srivastava S; Ahmad R; Khare SK
Eur J Med Chem; 2021 Apr; 216():113320. PubMed ID: 33652356
[TBL] [Abstract][Full Text] [Related]
11. Nanotechnology in the diagnostic and therapy for Alzheimer's disease.
Panghal A; Flora SJS
Biochim Biophys Acta Gen Subj; 2024 Mar; 1868(3):130559. PubMed ID: 38191034
[TBL] [Abstract][Full Text] [Related]
12. Nanotechnology Therapy for Alzheimer's Disease Memory Impairment Attenuation.
Ribarič S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499311
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Tau and Amyloid-β Targeted Immunotherapy Nanoparticles for Alzheimer's Disease.
Mashal Y; Abdelhady H; Iyer AK
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883556
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's Disease - Future Therapy Based on Dendrimers.
Aliev G; Ashraf GM; Tarasov VV; Chubarev VN; Leszek J; Gasiorowski K; Makhmutovа A; Baeesa SS; Avila-Rodriguez M; Ustyugov AA; Bachurin SO
Curr Neuropharmacol; 2019; 17(3):288-294. PubMed ID: 30227819
[TBL] [Abstract][Full Text] [Related]
15. Unravelling of molecular biomarkers in synaptic plasticity of Alzheimer's disease: Critical role of the restoration of neuronal circuits.
Pinky ; Neha ; Ali M; Tiwari P; Alam MM; Hattiwale HM; Jamal A; Parvez S
Ageing Res Rev; 2023 Nov; 91():102069. PubMed ID: 37696304
[TBL] [Abstract][Full Text] [Related]
16. Nanotechnology in Personalized Medicine: A Promising Tool for Alzheimer's Disease Treatment.
De Matteis L; Martín-Rapún R; de la Fuente JM
Curr Med Chem; 2018; 25(35):4602-4615. PubMed ID: 29022501
[TBL] [Abstract][Full Text] [Related]
17. Theranostic F-SLOH mitigates Alzheimer's disease pathology involving TFEB and ameliorates cognitive functions in Alzheimer's disease models.
Iyaswamy A; Wang X; Krishnamoorthi S; Kaliamoorthy V; Sreenivasmurthy SG; Kumar Durairajan SS; Song JX; Tong BC; Zhu Z; Su CF; Liu J; Cheung KH; Lu JH; Tan JQ; Li HW; Wong MS; Li M
Redox Biol; 2022 May; 51():102280. PubMed ID: 35286997
[TBL] [Abstract][Full Text] [Related]
18. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
Xie Y; Tan Y; Zheng Y; Du X; Liu Q
J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
[TBL] [Abstract][Full Text] [Related]
19. Advances in fluorescent probes for detection and imaging of amyloid-β peptides in Alzheimer's disease.
Zhang Y; Ding C; Li C; Wang X
Adv Clin Chem; 2021; 103():135-190. PubMed ID: 34229849
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
